AppYea Inc. (APYP)
OTC PINK OTC PINK Primary Summary
AppYea Chairman Bary Molchadsky Demonstrates Confidence by Converting Debt to Warrants with a Strike Price Set at a 250% Premium to Current Market Price of the Company's Common Stock
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / AppYea Inc. (OTCQB:APYP), developer of an innovative wearable monitoring solution to monitor and treat sleep apnea and snoring, today announced the conversion of the majority of debt owed to its Chairman, Boris (Bary) Molchadsky, who converted approximately $140,000 of debt into AppYea warrants with a strike price of $0.07 per share, reflecting a premium of more than 250% over the current market price of the Company's common shares. AppYea recently entered its commercial phase with the first deliveries of AppySleep to customers in the United States.
AppYea Inc. (APYP) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has AppYea Inc. ever had a stock split?
AppYea Inc. Profile
| Software Industry | Information Technology Sector | Yakir Abadi CEO | OTC PINK Exchange | 03834R205 CUSIP |
| IL Country | 3 Employees | - Last Dividend | 14 Mar 2022 Last Split | - IPO Date |
Overview
AppYea, Inc. is a pioneering digital health company founded in 2012 and headquartered in Gan Yavne, Israel. It specializes in developing innovative wearable monitoring solutions aimed at treating sleep apnea and snoring. Leveraging cutting-edge technology, AppYea focuses on improving the quality of sleep and overall well-being of individuals facing sleep-related disorders.
Products and Services
- AppySleep app: A sophisticated wristband equipped to monitor various physiological parameters during sleep. This tool is integral for those seeking a comprehensive understanding of their sleep patterns, aiming to enhance sleep quality through detailed monitoring.
- AppySleep: This biofeedback snoring treatment wristband stands out as a non-invasive solution designed to reduce snoring. By providing real-time feedback, it aids users in adjusting their sleeping positions to minimize snoring, thereby promoting a quieter, more restful sleep environment.
- AppySleep LAB: A medical-grade smartphone application that precisely monitors breathing patterns during sleep and identifies sleep apnea episodes without requiring physical contact with the user. It serves as a convenient and user-friendly method for individuals to assess their risk for sleep apnea from the comfort of their homes.
- AppySleep PRO: This advanced wristband is developed for the treatment of sleep apnea using biofeedback in conjunction with the AppySleep LAB app. It represents a holistic approach to sleep apnea therapy, combining wearable technology and app-based monitoring to offer an effective, user-centered treatment solution.
